Excalibur Fund Managers appeared to be the VC, which was created in 1996. The leading representative office of defined VC is situated in the London. The venture was found in Europe in United Kingdom.
The fund has exact preference in a number of founders of portfolio startups. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United Kingdom. Among the most successful fund investment fields, there are Biotechnology, Medical. Among the various public portfolio startups of the fund, we may underline BioVex, Neurotech, Ardana Bioscience
The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the Excalibur Fund Managers, startups are often financed by Techno Venture Management, Scottish Equity Partners, Avlar BioVentures. The meaningful sponsors for the fund in investment in the same round are 3i Group, Avlar BioVentures, Alice Ventures. In the next rounds fund is usually obtained by Scottish Equity Partners, GeneChem Inc., Avlar BioVentures.
The real fund results show that this VC is 24 percentage points more often commits exit comparing to other companies. The fund is constantly included in less than 2 investment rounds annually. The common things for fund are deals in the range of 10 - 50 millions dollars. The important activity for fund was in 2003. Comparing to the other companies, this Excalibur Fund Managers performs on 15 percentage points more the average number of lead investments. The increased amount of exits for fund were in 2005.
Besides them, we counted 3 critical employees of this fund in our database.
Related Funds
Funds with similar focus
Fund Name | Location |
Amsterdam Venture Partners | Amsterdam, Noord-Holland, The Netherlands |
Bilibili | China, Shanghai |
Cap-Meridian Ventures | New York, New York, United States |
Capital First | India, Maharashtra, Mumbai |
Deep30 | Chiyoda, Japan |
Dunamis Ventures | Central, Central Region, Singapore |
Enterprise Investment Scheme | - |
Etihad Airways | Abu Dhabi, Abu Dhabi Emirate, United Arab Emirates |
Jurisweb Interactiva | Barcelona, Catalonia, Spain |
NovaVest | - |
OCA Ventures | Chicago, Illinois, United States |
Philips Foundation | Missouri, Netherlands, United States |
SEED Venture | Massachusetts, Taunton, United States |
Shanghai SIIC Fund Management | China, Shanghai |
Songshu Touzi | Beijing, Beijing, China |
Suzanne and Walter Scott Foundation | - |
Thomas Swan & Co | Consett, England, United Kingdom |
Xinlan Investment | Beijing, Changping, China |
Yello Mobile | Seoul, Seoul-t'ukpyolsi, South Korea |
Zhejiang Xunguang Touzi Guanli Youxian Gongsi | China, Zhejiang, Zhoushan |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Neurotech | $35M | 16 Nov 2006 | Rhode Island, United States | ||
Onyvax | $10M | 08 May 2006 | Somerset West and Taunton, England, United Kingdom | ||
Plethora Solutions | 01 Jan 2004 | United Kingdom, England | |||
$32M | 30 Jul 2003 | United Kingdom, Scotland | |||
Piramed | $13M | 09 Jul 2003 | United Kingdom, England, United Kingdom | ||
Arakis Limited | $21M | 26 Apr 2002 | London, England, United Kingdom | ||
$36M | 20 Feb 2002 | United Kingdom, England, United Kingdom | |||
$20M | 22 Oct 2001 | City of Edinburgh, Scotland, United Kingdom | |||
EpiCept Corporation | $13M | 10 Jan 2001 | New Jersey, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Neurotech | $35M | 16 Nov 2006 | Rhode Island, United States | ||
Onyvax | $10M | 08 May 2006 | Somerset West and Taunton, England, United Kingdom | ||
Plethora Solutions | 01 Jan 2004 | United Kingdom, England | |||
$32M | 30 Jul 2003 | United Kingdom, Scotland | |||
Piramed | $13M | 09 Jul 2003 | United Kingdom, England, United Kingdom | ||
Arakis Limited | $21M | 26 Apr 2002 | London, England, United Kingdom | ||
$36M | 20 Feb 2002 | United Kingdom, England, United Kingdom | |||
$20M | 22 Oct 2001 | City of Edinburgh, Scotland, United Kingdom | |||
EpiCept Corporation | $13M | 10 Jan 2001 | New Jersey, United States |